Director, Legal
Mineralys Therapeutics
Director, Legal
Mineralys Therapeutics
Clinical-stage biopharma targeting aldosterone synthesis
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, Twitter and Bluesky”
Mineralys is a fully remote company.
Director, Legal
The Director, Legal (Commercial and Medical Review) will serve as the lead legal reviewer for promotional and medical materials. This individual will represent Legal in the Medical, Legal, and Regulatory (MLR) review process, will sit on the Promotional Review Committee (PRC) and Medical Review Committee (MRC), and will help design the standards and procedures that allow the company to review materials quickly, through planned launch and into commercialization. This is a hands-on role for an attorney who is comfortable giving clear, practical advice in a fast-moving, remote environment and appreciates autonomy.
Reporting to the VP, Commercial Legal, this role is accountable for providing practical legal guidance across advertising and promotion, medical affairs activities, commercial operations, market access initiatives, and product launch planning.
This role requires strong interpersonal skills and significant cross-functional interaction across Commercial, Medical Affairs, Regulatory, Legal and Compliance. Experience with patient support programs and related materials would be an asset to the role.
Key Responsibilities
Qualifications
Core Competencies
Travel
This position is eligible for standard Company benefits including medical, dental, vision, time off and 401K, as well as participating in Mineralys incentive plans are contingent on achievement of personal and company performance. Actual compensation may vary from posted hiring range based on geographic location, work experience, education, and/or skill level.
US Salary Range: $250,000 - $275,000
#LI-Remote
Clinical-stage biopharma targeting aldosterone synthesis
Mineralys Therapeutics develops targeted treatments for diseases driven by dysregulated aldosterone, aiming to control blood pressure and prevent organ damage, led by lorundrostat. Lorundrostat is an oral aldosterone synthase inhibitor that blocks the CYP11B2 enzyme to lower aldosterone production, designed to reduce blood pressure with minimal cortisol disruption due to high selectivity. Compared with older non-selective MRAs, it lowers side effects by focusing on aldosterone synthesis rather than receptor blockade. The company's goal is to advance lorundrostat through late-stage trials toward regulatory approval and commercialization, while exploring expanded uses in CKD and OSA for a potential multi-hundred-billion market.
Explore more opportunities at Mineralys Therapeutics